16 reports

ADVANCES IN ADCS TECHNOLOGY ADVANCES IN ADCS TECHNOLOGY ADVANCES IN INSULIN DELIVERY TECHNOLOGY The development of innovative insulin products and advances in insulin delivery technology have increased the life expectancy of individuals with diabetes.

  • Generic Drug
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • 9.2 BIOCON
  • 9.2 BIOCON

The global insulin delivery device market, estimated at USD ##. ## billion, in 2014.

  • Generic Drug
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.

In refractory patients consider adding TZD or SGLT##I: Basal insulin + Mealtime insulin or GLP-## RA TZD SU or or SGLT##I Insulin or or DPP-##I Insulin GLP-## RA + or or TZD Insulin Metformin + Insulin (basal) + or DPP-##I or SGLT##I o

  • Generic Drug
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.
  • LANTUS IS EXPECTED TO BE THE LEADING INSULIN ANALOG TILL 2020
  • KEY FINDINGS

The global human insulin market is poised to reach ~USD 39.13 billion by 2020 growing at a CAGR of 8.1% from 2015 to 2020. North America is expected to hold the largest share of the global human insulin market in 2015. Market growth of human insulin products is being propelled by growing diabetes patient population, increasing population exposure...

  • Generic Drug
  • North America
  • United States
  • Market Size
  • Novo Nordisk Group

In October, Biocon launched its reusable insulin delivery device INSUPen in India.

  • Biosimilar
  • Generic Drug
  • India
  • Company Financials
  • Biocon Limited

DIRECT ACTIVATION OF THE ANGIOTENSIN II ##-JAN-2018 Type-## Receptors Enhances Muscle Micro vascular Perfusion, Oxygenation and Insulin Delivery in Male Rats".

  • Biotech
  • Generic Drug
  • United States
  • Company
  • Product Initiative

DIRECT ACTIVATION OF THE ANGIOTENSIN II TYPE-## RECEPTORS ENHANCES MUSCLE MICROVASCULAR PERFUSION, OXYGENATION AND INSULIN DELIVERY IN MALE RATS".

  • Autoimmune Disease
  • Generic Drug
  • United States
  • Company
  • Product Initiative

IT IS PREFILLED INSULIN DELIVERY DEVICE.

  • Generic Drug
  • North America
  • United States
  • World
  • Market Size

Closed-loop insulin delivery: from bench to clinical practice.

  • Generic Drug
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Sanofi S.A.

THE LATEST GENERATION OF DELIVERY SYSTEMS TO ARRIVE ON THE MARKET IS INSULIN INJECTOR PENS.

  • Generic Drug
  • United States
  • Hospira, Inc.
  • Roche Group
  • Sandoz Inc.

Closed-loop insulin delivery: from bench to clinical practice.

  • Generic Drug
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

Closed-loop insulin delivery: from bench to clinical practice.

  • Generic Drug
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

Closed-loop insulin delivery: from bench to clinical practice.

  • Generic Drug
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

Closed-loop insulin delivery: from bench to clinical practice.

  • Generic Drug
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

Parenteral administration of drugs is one of the most popular methods of drug delivery.

  • Generic Drug
  • World
  • Baxter International Inc.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • HUMAN INSULIN: MARKETED BIOSIMILARS
  • 5.7.3.3. BIOSIMILARS PRODUCT PORTFOLIO

INTRODUCTION Characterised by increased utility in chronic diseases and capital intensive manufacturing, the global biopharmaceutical market is expanding robustly. As the demand for biologics is increasing continuously, manufacturers are on the lookout for novel strategies that will help them attain maximum returns on investment.Derived...

  • Generic Drug
  • North America
  • United States
  • Market Size
  • Sandoz Inc.